ConductScience.org, home

Paper32117751

Preclinical Models of Malignant Mesothelioma.

Testa JR and 1 other. Front Oncol, 2020. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Preclinical Models of Malignant Mesothelioma. Papers, record 32117751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32117751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preclinical Models of Malignant Mesothelioma.
PubMed
Journal
Front Oncol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2020-09-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Testa JRJoseph R
2Berns AAnton

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References74

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130410729Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort.F1000Res2018https://conductscience.org/library/papers/30410729PubMed
224371224Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.Cancer Res2014https://conductscience.org/library/papers/24371224PubMed
35360333Mesotheliomas in rats following inoculation with asbestos.Br J Cancer1969https://conductscience.org/library/papers/5360333PubMed
420672017A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma.Genes Cancer2010https://conductscience.org/library/papers/20672017PubMed
53180061Chromosomal translocations with specific breakpoints in asbestos-induced rat mesotheliomas.Cancer Res1988https://conductscience.org/library/papers/3180061PubMed
626928227Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.Nat Genet2016https://conductscience.org/library/papers/26928227PubMed
77546219Effects of genetic background on tumorigenesis in p53-deficient mice.Mol Carcinog1995https://conductscience.org/library/papers/7546219PubMed
826896281Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.Cancer Res2016https://conductscience.org/library/papers/26896281PubMed
911936818Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium).Cancer Causes Control2002https://conductscience.org/library/papers/11936818PubMed
1030322867Integrative Molecular Characterization of Malignant Pleural Mesothelioma.Cancer Discov2018https://conductscience.org/library/papers/30322867PubMed
117923195p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.Cancer Res1994https://conductscience.org/library/papers/7923195PubMed
1226437366Loss of BAP1 function leads to EZH2-dependent transformation.Nat Med2015https://conductscience.org/library/papers/26437366PubMed
1317557954Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.J Clin Oncol2007https://conductscience.org/library/papers/17557954PubMed
1420104527Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.Int J Cancer2010https://conductscience.org/library/papers/20104527PubMed
1520436301Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA.Cell Cycle2010https://conductscience.org/library/papers/20436301PubMed
1621526190Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.PLoS One2011https://conductscience.org/library/papers/21526190PubMed
1726719535Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.Cancer Res2016https://conductscience.org/library/papers/26719535PubMed
18663877An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgüp in Anatolia.Thorax1978https://conductscience.org/library/papers/663877PubMed
192986668Erionite exposure and mesotheliomas in rats.Br J Cancer1985https://conductscience.org/library/papers/2986668PubMed
2015451223Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids.Lancet2004https://conductscience.org/library/papers/15451223PubMed

See all 74 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42208538Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity.Med2026https://conductscience.org/library/papers/42208538PubMed
41673140Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models.Sci Rep2026https://conductscience.org/library/papers/41673140PubMed
40775245Pleural mesothelioma.Nat Rev Dis Primers2025https://conductscience.org/library/papers/40775245PubMed
40559443A Minimally Invasive Transthoracic Injection Technique for Reproducible Intrapleural Delivery in Mice.Methods Protoc2025https://conductscience.org/library/papers/40559443PubMed
39831064Editorial: Asbestos and disease genomics: is mesothelioma a genomic paradigm?Front Toxicol2024https://conductscience.org/library/papers/39831064PubMed
39791266Modeling Malignant Mesothelioma in Genetically Engineered Mice.Curr Protoc2025https://conductscience.org/library/papers/39791266PubMed
39447016An evaluation of trends for mesothelioma mortality in American women: Addressing the content of a recent Morbidity and Mortality Weekly Report (MMWR).Toxicol Ind Health2025https://conductscience.org/library/papers/39447016PubMed
38592450Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment.Cancer Res Commun2024https://conductscience.org/library/papers/38592450PubMed
38297314Malignant peritoneal mesotheliomas of rats induced by multiwalled carbon nanotubes and amosite asbestos: transcriptome and epigenetic profiles.Part Fibre Toxicol2024https://conductscience.org/library/papers/38297314PubMed
37568732Predicting Overall Survival for Patients with Malignant Mesothelioma Following Radiotherapy via Interpretable Machine Learning.Cancers (Basel)2023https://conductscience.org/library/papers/37568732PubMed
36685577Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics.Front Immunol2022https://conductscience.org/library/papers/36685577PubMed
36355620Inflammation as a chemoprevention target in asbestos-induced malignant mesothelioma.Carcinogenesis2022https://conductscience.org/library/papers/36355620PubMed
35832452Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow.Transl Lung Cancer Res2022https://conductscience.org/library/papers/35832452PubMed
35804881Mesothelioma Mouse Models with Mixed Genomic States of Chromosome and Microsatellite Instability.Cancers (Basel)2022https://conductscience.org/library/papers/35804881PubMed
35785199Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects.Front Oncol2022https://conductscience.org/library/papers/35785199PubMed
34830817Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms.Cancers (Basel)2021https://conductscience.org/library/papers/34830817PubMed
34440833Generation, Characterization, and Application of Inducible Proliferative Adult Human Epicardium-Derived Cells.Cells2021https://conductscience.org/library/papers/34440833PubMed
34235080How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers.Front Oncol2021https://conductscience.org/library/papers/34235080PubMed
33692175Use of preclinical models for malignant pleural mesothelioma.Thorax2021https://conductscience.org/library/papers/33692175PubMed
33380218Mouse models for mesothelioma drug discovery and development.Expert Opin Drug Discov2021https://conductscience.org/library/papers/33380218PubMed

See all 21 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32117751

GET https://conductscience.org/api/papers/v1/32117751/references?page=2